Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Net Income (2016 - 2025)

Historic Net Income for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' Net Income rose 4775.57% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 580.51%. This contributed to the annual value of -$10.7 million for FY2024, which is 3039.44% up from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Net Income of -$1.4 million as of Q3 2025, which was up 4775.57% from -$4.0 million recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Net Income ranged from a high of -$1.4 million in Q3 2025 and a low of -$4.6 million during Q4 2021
  • Its 5-year average for Net Income is -$3.4 million, with a median of -$3.4 million in 2021.
  • Examining YoY changes over the last 5 years, Ekso Bionics Holdings' Net Income showed a top increase of 4775.57% in 2025 and a maximum decrease of 6770.44% in 2025.
  • Ekso Bionics Holdings' Net Income (Quarter) stood at -$4.6 million in 2021, then increased by 1.87% to -$4.5 million in 2022, then grew by 21.92% to -$3.5 million in 2023, then skyrocketed by 34.88% to -$2.3 million in 2024, then skyrocketed by 37.96% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$4.0 million for Q2 2025, and -$3.5 million during Q1 2025.